These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12878901)

  • 21. Platelet nitric oxide production and IR: relation with obesity and hypertriglyceridemia.
    Vignini A; Nanetti L; Moroni C; Testa R; Sirolla C; Marra M; Cenerelli S; Gregori A; Fumelli D; Olivieri F; Mazzanti L; Rabini RA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):553-8. PubMed ID: 18155481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelets and heart failure.
    Chung I; Lip GY
    Eur Heart J; 2006 Nov; 27(22):2623-31. PubMed ID: 17028108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin inhibition of platelet-endothelial interaction is mediated by insulin effects on endothelial cells without direct effects on platelets.
    Rauchfuss S; Geiger J; Walter U; Renne T; Gambaryan S
    J Thromb Haemost; 2008 May; 6(5):856-64. PubMed ID: 18284601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet inhibition by insulin is absent in type 2 diabetes mellitus.
    Ferreira IA; Mocking AI; Feijge MA; Gorter G; van Haeften TW; Heemskerk JW; Akkerman JW
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):417-22. PubMed ID: 16339499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of plasma nitric oxide levels on platelet activation in single donor apheresis and random donor concentrates.
    Büyükkağnici DI; Ilhan O; Kavas GO; Arslan O; Arat M; Dalva K; Ayyildiz E
    Transfus Apher Sci; 2007 Feb; 36(1):73-8. PubMed ID: 17236811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone.
    Randriamboavonjy V; Pistrosch F; Bölck B; Schwinger RH; Dixit M; Badenhoop K; Cohen RA; Busse R; Fleming I
    Circulation; 2008 Jan; 117(1):52-60. PubMed ID: 18071073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disturbances of the coagulating equilibrium of blood in diabetes mellitus.
    Sfredel V; Moţa M; Trăilă A; Dănoiu S; Matcaş H
    Rom J Intern Med; 1999; 37(3):251-60. PubMed ID: 15532303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet activation and apoptosis are different phenomena: evidence from the sequential dynamics and the magnitude of responses during platelet storage.
    Leytin V; Allen DJ; Mutlu A; Mykhaylov S; Lyubimov E; Freedman J
    Br J Haematol; 2008 Jul; 142(3):494-7. PubMed ID: 18492095
    [No Abstract]   [Full Text] [Related]  

  • 29. [Platelets and the fibrinolytic system].
    Komarnicki M; Kaźmierczak M
    Acta Haematol Pol; 1993; 24(3):233-7. PubMed ID: 8249539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes mellitus as a prothrombotic condition.
    Grant PJ
    J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of nitric oxide in cardiovascular diseases.
    Naseem KM
    Mol Aspects Med; 2005; 26(1-2):33-65. PubMed ID: 15722114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet and phagocyte activation. A series of papers from the Blood Cells Symposium. April 1989, Banff, Alberta, Canada. Proceedings.
    Blood Cells; 1990; 16(1):1-216. PubMed ID: 2350586
    [No Abstract]   [Full Text] [Related]  

  • 33. Endogenously generated reactive oxygen species reduce PMCA activity in platelets from patients with non-insulin-dependent diabetes mellitus.
    Jardín I; Redondo PC; Salido GM; Pariente JA; Rosado JA
    Platelets; 2006 Aug; 17(5):283-8. PubMed ID: 16928598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
    Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quebec platelet disorder: features, pathogenesis and treatment.
    Diamandis M; Veljkovic DK; Maurer-Spurej E; Rivard GE; Hayward CP
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):109-19. PubMed ID: 18277131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diabetes mellitus and platelet function].
    Amado JA
    Rev Clin Esp; 1988 Jul; 183(3):158-9. PubMed ID: 3187133
    [No Abstract]   [Full Text] [Related]  

  • 37. [Brain protection--update].
    Sakabe T; Sano T
    Masui; 1995; 44 Suppl():S45-51. PubMed ID: 8544324
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet count and platelet activation: impact of a fat meal and day time.
    Wiens L; Lutze G; Luley C; Westphal S
    Platelets; 2007 Mar; 18(2):171-3. PubMed ID: 17365867
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacotherapeutical features of arterial hypertension in patients with diabetes mellitus].
    Okunevich IV; Khnychenko LK; Sapronov NS
    Klin Med (Mosk); 2007; 85(1):52-7. PubMed ID: 17419357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes mellitus: pathogenesis and treatment strategies.
    Skyler JS
    J Med Chem; 2004 Aug; 47(17):4113-7. PubMed ID: 15293979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.